Scaffold

Details for Australian Patent Application No. 2006256530 (hide)

Owner Medical Research Council

Inventors Laurenson, Sophie; Yeh, Johannes Tsung-Han; Ko Ferrigno, Paul; Woodman, Robbie

Agent Wrays

Pub. Number AU-A-2006256530

PCT Pub. Number WO2006/131749

Priority 0511873.2 10.06.05 GB; 0608836.3 04.05.06 GB

Filing date 8 June 2006

Wipo publication date 14 December 2006

International Classifications

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131749 Priority application(s): WO2006/131749

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256531-Lipase polypeptide

2006256525-Resisting the spread of unwanted code and data